Full Press Release Details
SAN DIEGO , Jan. 9, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be presenting at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 16, 2014 at 10:00 a.m. PT / 1:00 p.m. ET . Helen Torley , M.B. Ch. B., M.R.C.P., President and Chief Executive Officer of Halozyme Therapeutics, will provide a corporate overview.
The presentation will be webcast through the "Investors" section of Halozyme's corporate website at www.halozyme.com , and a recording will be made available for 90 days following the event. To access the live webcast, please log on to Halozyme's website approximately fifteen minutes prior to the presentation to register and download any necessary audio software.
Investor Contact: Schond Greenway Halozyme Therapeutics 858-704-8352 [email protected]
Media Contact: Nurha Hindi Hill + Knowlton Strategies 310-633-9434 [email protected]
SOURCE Halozyme Therapeutics, Inc.